Biologics distribution for Cleveland medspas and aesthetic practices

Ingredient and lot documentation for aesthetic use

Aesthetic practices reviewing a lyophilized exosome or Wharton's jelly product for the first time often ask for the full ingredient disclosure alongside the certificate of analysis and donor eligibility summary, since some formats include added peptides or growth factors disclosed on request. Precision Biologics provides this documentation to verified accounts rather than publishing specifications broadly, since details are specific to the lot and product format.

Physician supervision drives the review

Because medspas and aesthetic practices in Cleveland operate under physician supervision, the decision to add a new biologics line typically goes through the supervising physician or medical director rather than through non-clinical staff, and that review generally includes a look at the vendor's licensure and the regulatory classification of the specific product being considered.

Account setup and ordering

Precision Biologics opens accounts for licensed professionals once an NPI number is verified, and pricing is released only after that step is complete. The process is the same for a Cleveland medspa as it is for any other licensed practice.

Confirming standing and getting support

Precision Biologics recommends that a Cleveland-area aesthetic practice confirm its own standing with the Ohio medical board and review the applicable regulatory framework with its own counsel before purchasing, since Precision Biologics does not advise on clinical use or protocols. Account setup support includes registration and licensure documentation on request and physician-level calls focused on product documentation.

These products are not FDA approved or licensed for any disease or condition. Information here is for licensed healthcare professionals and is not medical or legal advice.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.